Identification of regulatory cis-acting elements for alternative splicing of presenilin 2 exon 5 under hypoxic stress conditions

Journal of Neurochemistry

Volumn 91, Issue 5, 2004, Pages 1191-1198

  Higashide, Satoshi ^a   Morikawa, Keisuke ^a   Okumura, Masayo ^a   Kondo, Shinichi ^a   Ogata, Maiko ^a   Murakami, Tomohiko ^a   Yamashita, Akinori ^a   Kanemoto, Soshi ^a   Manabe, Takayuki ^b   Imaizumi, Kazunori ^a  

^a NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

cis acting elements; Exon trapping; Exonic splicing enhancer; mRNA splicing; Presenilin 2

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CIS ACTING ELEMENT; NUCLEOTIDE; PRESENILIN 2; PRESENILIN 5; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; EXON; GENE SEQUENCE; HUMAN; HUMAN CELL; HYPOXIA; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN VARIANT; RNA SPLICING; RNA STRUCTURE; STRESS; STRUCTURAL CHROMOSOME ABERRATION;

ALTERNATIVE SPLICING; ALZHEIMER DISEASE; ANOXIA; BRAIN; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; EXONS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MODELS, MOLECULAR; MUTAGENESIS; NEUROBLASTOMA; NICKEL; NITROGEN; OLIGORIBONUCLEOTIDES, ANTISENSE; PRESENILIN-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STRESS; TAU PROTEINS;

EID: 9744260941     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02798.x     Document Type: Article

References (20)

1. Behrooz A. and Ismail-Beigi F. (1999) Stimulation of glucose transport by hypoxia: signals and mechanisms. News Physiol. Sci. 14, 105-110.
2. Blencowe B. J. (2000) Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25, 106-110.
3. Cartegni L., Chew S. L. and Krainer A. R. (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285-298.
4. Church D. M., Stotler C. J., Rutter J. L., Murrell J. R., Trofatter J. A. and Buckler A. J. (1994) Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nat. Genet. 6, 98-105.
5. De Jonghe C., Cruts M., Rogaeva E. A. et al. (1999) Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion. Hum. Molec. Genet. 8, 1529-1540.
6. Duranteau J., Chandel N. S., Kulisz A., Shao Z. and Schumacker P. T. (1998) Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J. Biol. Chem. 273, 11 619-11 624.
7. Hutton M., Lendon C. L., Rizzu P. et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
8. Lin C. L., Bristol L. A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L. and Rothstein J. D. (1998) Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20, 589-602.
9. Manabe T., Katayama T., Sato N., Kudo T., Matsuzaki S., Imaizumi K. and Tohyama M. (2002) The cytosolic inclusion bodies that consist of splice variants that lack exon 5 of the presenilin-2 gene differ obviously from Hirano bodies observed in the brain from sporadic cases of Alzheimer's disease patients. Neurosci. Lett. 328, 198-200.
10. Manabe T., Katayama T., Sato N. et al. (2003) Induced HMGA1a expression causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimer's disease. Cell Death Differ. 10, 698-708.
11. Maniatis T. (1991) Mechanisms of alternative pre-mRNA splicing. Science 251, 33-34.
12. Matsuzaki S., Manabe T., Katayama T., Nishikawa A., Yanagita T., Okuda H., Yasuda Y., Miyata S., Meshitsuka S. and Tohyama M. (2004) Metals accelerate production of the aberrant splicing isoform of the presenilin-2. J. Neurochem. 88, 1345-1351.
13. Miyajima H., Miyaso H., Okumura M., Kurisu J. and Imaizumi K. (2002) Identification of a cis-acting element for the regulation of SMN exon 7 splicing. J. Biol. Chem. 277, 23 271-23 277.
14. Perez-Tur J., Froelich S., Prihar G. et al. (1995) A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7, 297-301.
15. Prihar G., Fuldner R. A., Perez-Tur J. et al. (1996) Structure and alternative splicing of the presenilin-2 gene. Neuroreport 7, 1680-1684.
16. Sato N., Hori O., Yamaguchi A. et al. (1999) A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue. J. Neurochem. 72, 2498-2505.
17. Sato N., Imaizumi K., Manabe T. et al. (2001) Increased production of beta-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2. J. Biol. Chem. 276, 2108-2114.
18. Smith C. W., Patton J. G. and Nadal-Ginard B. (1989) Alternative splicing in the control of gene expression. Ann. Rev. Genet. 23, 527-577.
19. Tysoe C., Whittaker J., Xuereb J., Cairns N. J., Cruts M., Van-Broeckhoven C., Wilcock G. and Rubinsztein D. C. (1998) A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease. Am. J. Hum. Genet. 62, 70-76.
20. Zuker M. (1989) On finding all suboptimal foldings of an RNA molecule. Science 244, 48-52.